Cellulite Clinical Trials 2023

What are the top hospitals conducting cellulite research?

When it comes to tackling the persistent issue of cellulite, several hospitals are leading the way in innovative clinical trials. In Sacramento, California, the Laser & Skin Surgery Center takes center stage with two active cellulite trials and a total of two completed trials. Their dedication to finding effective solutions for this common concern is evident as they initiated their first trial in 2021. Joining them in the mission to combat cellulite is the Innovation Research Center in Pleasanton, which also boasts two ongoing trials and has made significant progress with one completed trial since its inaugural study was recorded in 2022.

Further east, Schweiger Dermatology GP Research located in Hackensack has dedicated substantial resources towards understanding and treating cellulite. With one active clinical trial currently underway and an additional trial previously conducted, this hospital is making strides within this specialized field. Meanwhile, UnionDerm situated amidst New york's bustling metropolis focuses on providing cutting-edge solutions for patients battling cellulite. They are actively engaged in one clinical trial while having accomplished two previous studies since commencing their research efforts back in 2021.

Lastly but not leastly Main Line Center for Laser Surgery nestled within Ardmore joins these esteemed institutions by contributing valuable insights into combating cellulite through their current active clinical trial paired with one past investigation; both launched as recently as 2023.

These hospitals across different regions demonstrate unwavering commitment and determination to address a cosmetic condition that affects many individuals globally. By prioritizing research and exploration into new treatment options for cellulite, they offer hope that someday we may unlock more effective strategies for managing this common concern that often impacts self-esteem.

Which are the best cities for cellulite clinical trials?

When it comes to cellulite clinical trials, several cities are at the forefront of research and development. New york, New York leads with 5 active trials focused on studying cellulite treatments like CBL-514 up to 320mg and Rapid Acoustic Pulse (RAP). Sacramento, California; Hackensack, New jersey; San Diego, California; and Chicago, Illinois follow closely behind with 2 ongoing trials each exploring various interventions for cellulite reduction. These cities provide individuals interested in participating in cellulite clinical trials with opportunities to contribute to advancements in treatment options and overall knowledge about this common cosmetic concern.

Which are the top treatments for cellulite being explored in clinical trials?

Cellulite, a common concern for many individuals, has spurred research into innovative treatments. At the forefront is Sofwave, currently undergoing one active clinical trial specifically targeting cellulite. Since its introduction in 2021, it has already garnered two all-time trials dedicated to addressing this cosmetic issue. With ongoing efforts and advancements in technology, researchers strive to uncover effective solutions that can help individuals combat cellulite and boost their self-confidence.

What are the most recent clinical trials for cellulite?

Recent clinical trials have been exploring innovative approaches to address the issue of cellulite. One such trial investigated the effectiveness of CBL-514 at various dosage levels, up to 320mg, in reducing the appearance of cellulite. Another study focused on a treatment called Rapid Acoustic Pulse (RAP), which has shown promise in improving cellulite. With Phase 4 studies conducted over multiple time periods, RAP continues to be evaluated for its potential benefits. These ongoing efforts reflect a commitment to finding effective solutions for individuals struggling with cellulite and improving their quality of life.

What cellulite clinical trials were recently completed?

Recently, a noteworthy clinical trial focusing on cellulite has concluded, marking a step forward in the search for effective treatments. In June 2022, Endo Pharmaceuticals successfully completed their sponsored trial investigating the potential of CCH-aaes. This significant milestone brings optimism to those seeking solutions to address cellulite-related concerns.